Earnings News

Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.

Redwire Soars 20% on Record Backlog, ATM Offering Raises Dilution Concerns
Earnings James Calloway

Redwire Soars 20% on Record Backlog, ATM Offering Raises Dilution Concerns

Redwire shares jumped 20% on a record $498.1M backlog and reaffirmed 2026 revenue outlook, but a $350M stock offering plan tempers investor enthusiasm.

RDW
JFrog Shares Soar 24% as AI Coding Surge Drives Cloud Revenue Growth
Earnings James Calloway

JFrog Shares Soar 24% as AI Coding Surge Drives Cloud Revenue Growth

JFrog shares surged 23.7% to $70.55 after Q1 revenue rose 26% to $154M, cloud revenue jumped 50%, and the company raised its 2026 outlook.

FROG
Earnings James Calloway

Virgin Galactic Shares Soar 17% Ahead of Earnings; Focus on Cash Burn

Virgin Galactic stock jumped 17% to $2.94 ahead of next week's earnings, as investors await Delta spacecraft flight tests and commercial service restart. Cash burn remains the critical concern.

SPCE
HP Stock Surges Ahead of Earnings as AI PC Hype Meets Margin Pressure
Earnings James Calloway

HP Stock Surges Ahead of Earnings as AI PC Hype Meets Margin Pressure

HP Inc. shares jumped 8% to $22.68 on Friday, rebounding ahead of its fiscal Q2 earnings report on May 27, with AI PC demand and rising memory costs in focus.

HPQ DELL AAPL
Cisco Shares Rally Ahead of Key Q3 Earnings as AI Revenue Conversion Takes Center Stage
Earnings James Calloway

Cisco Shares Rally Ahead of Key Q3 Earnings as AI Revenue Conversion Takes Center Stage

Cisco shares jumped 4.7% to $96.52 ahead of its fiscal Q3 earnings on May 13, with analysts eyeing AI order conversion and margin performance.

CSCO
Hims & Hers Health Gears for Earnings Amid Weight-Loss Drug Shifts
Earnings James Calloway

Hims & Hers Health Gears for Earnings Amid Weight-Loss Drug Shifts

Hims & Hers Health shares surged 9.3% to $28.03 ahead of its May 11 earnings report, with options pricing a 14.8% move. The company is navigating FDA rules on compounded weight-loss drugs.

HIMS
Prospect Capital Shares Slide on Earnings Miss and Dividend Cut
Earnings James Calloway

Prospect Capital Shares Slide on Earnings Miss and Dividend Cut

Prospect Capital shares dropped 9.6% after Q1 net investment income fell to $78.5 million and the company cut its monthly dividend to $0.035 per share.

PSEC
DXC Technology Shares Tumble 23% on Weak Revenue Outlook and AI Turnaround Doubts
Earnings James Calloway

DXC Technology Shares Tumble 23% on Weak Revenue Outlook and AI Turnaround Doubts

DXC Technology shares fell 23% after forecasting further organic revenue declines and reporting a GAAP loss, casting doubt on its AI-driven turnaround amid weak demand.

DXC
Main Street Capital Shares Slide on Q1 Earnings Miss Amid Dividend Coverage Concerns
Earnings James Calloway

Main Street Capital Shares Slide on Q1 Earnings Miss Amid Dividend Coverage Concerns

Main Street Capital shares fell 4.5% after Q1 earnings missed estimates, raising questions about dividend sustainability amid credit quality concerns.

MAIN
Earnings James Calloway

Motorola Solutions Shares Fall 11% Despite Lifted 2026 Guidance

Motorola Solutions raised its 2026 revenue forecast to $12.8B after a solid Q1, but shares tumbled 11% as investors wanted a bigger boost.

MSI AXON
nLIGHT Soars on Record Defense Revenue, 55% Sales Jump
Earnings James Calloway

nLIGHT Soars on Record Defense Revenue, 55% Sales Jump

nLIGHT shares surged 10.3% after Q1 revenue jumped 55% to $80.2M, driven by record aerospace and defense sales, with the company swinging to a profit and launching its HADES laser system.

LASR
Opendoor Shares Slide as Q1 Loss Widens Despite Revenue Beat
Earnings James Calloway

Opendoor Shares Slide as Q1 Loss Widens Despite Revenue Beat

Opendoor Technologies shares dropped 4.5% following a first-quarter net loss of $173 million, wider than last year, though revenue of $720 million beat analyst estimates. The company doubled acquisition contracts but sold fewer homes.

OPEN